MAPK4 emerges as a novel therapeutic target for triple-negative breast cancer
Scientific evidence supporting the involvement of the enzyme MAPK4 in cancer growth and resistance to certain therapies has been growing quickly. In a current study published in the journal Nature Communications, a team at ...
Jan 11, 2022
0
88